CPC technology class · D04
D04C - Braiding Or Manufacture Of Lace
Braiding or manufacture of lace, including bobbin-net or carbonised lace; braiding machines; braid; lace. 584 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.
- 584
- US patents granted
- #3/5
- in D04
- 9.8%
- D04 class share
- +12%
- 5-yr velocity
The verdict
According to USPTO PatentsView, Braiding Or Manufacture Of Lace ranks #521 of 670 CPC technology areas - 584 US patents granted since 2015, with recorded grant volume up 12% over five years.
- #521
- of 670 CPC technology areas
- 584
- US patents granted, 2015–2025
- Nike
- leading assignee (29)
- +12%
- grant velocity, last 5 yrs
How D04C's grant cadence moved
Between 2020–2024, D04C recorded 282 grants versus 252 in 2015–2019 (+12% equal-window velocity). Across complete years, output peaked in 2022 at 67 grants and bottomed in 2016 at 41 (+63% peak-over-trough). Lead assignee Boston Scientific Scimed, Inc. holds 3.9% of the class ; the top three share 10.6%.
Leaderboard read
D04C concentration, lead at 3.9%
Boston Scientific Scimed, Inc. leads this historical grant record at 3.9% of D04C - us corporation assignees hold 75% of class grants (222 of 297). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.
- Leader's share
- 3.9%
- Top three share
- 10.6%
- Lead over #2
- 0
23 of 584 grants
of the class's recorded grants
more grants than Federal-Mogul Powertrain LLC
Where D04C sits inside D04
Among 5 subclasses in D04 (BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; Non-woven Fabrics), D04C ranks #3 and holds 9.8% of the parent class's 5,966 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.
Rising assignees active in D04C
Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.
- #1 Syntorr Inc. 3.00x 1 → 3 company-wide · 5 in D04C
- #2 A&P Technology, Inc. 2.50x 2 → 5 company-wide · 9 in D04C
- #3 EverestMedica LLC 2.50x 2 → 5 company-wide · 8 in D04C
- #4 Occlutech GmbH 1.40x 5 → 7 company-wide · 13 in D04C
- #5 MicroVention, Inc. 1.26x 65 → 82 company-wide · 8 in D04C
D04C grants by year, peak 2022 (67)
US utility-patent grants per year in D04C, 2015–2025 - recent five years are up 12% versus 2015–2019.
Who leads D04C?
The 12 most active assignees in Braiding OR Manufacture OF Lace, Including Bobbin-net OR Carbonised LACE; Braiding MACHINES; BRAID; Lace - wider bars mean more grants
- Boston Scientific…
Boston Scientific Scimed, Inc.
23 patents
- Federal-mogul…
Federal-Mogul Powertrain LLC
23 patents
- Insera Therapeutics
Insera Therapeutics, Inc.
16 patents
- Occlutech
Occlutech GmbH
13 patents
- Biomet Sports Medicine
Biomet Sports Medicine, LLC
11 patents
- Idev
IDev Technologies, Inc.
10 patents
- Tepha 9
Tepha, Inc.
9 patents
- A&P Technology 9
A&P Technology, Inc.
9 patents
- C R Bard 8
C.R. Bard, Inc.
8 patents
- Microvention 8
MicroVention, Inc.
8 patents
- Everestmedica 8
EverestMedica LLC
8 patents
- Woven Orthopedic 7
Woven Orthopedic Technologies, LLC
7 patents
What this shows Nike is the most active filer in D04C, holding 29 of the 584 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in D04C |
|---|---|---|
| #1 | Boston Scientific Scimed, Inc. | 23 |
| #2 | Federal-Mogul Powertrain LLC | 23 |
| #3 | Insera Therapeutics, Inc. | 16 |
| #4 | Occlutech GmbH | 13 |
| #5 | Biomet Sports Medicine, LLC | 11 |
| #6 | IDev Technologies, Inc. | 10 |
| #7 | Tepha, Inc. | 9 |
| #8 | A&P Technology, Inc. | 9 |
| #9 | C.R. Bard, Inc. | 8 |
| #10 | MicroVention, Inc. | 8 |
| #11 | EverestMedica LLC | 8 |
| #12 | Woven Orthopedic Technologies, LLC | 7 |
| #13 | Sequent Medical, Inc. | 6 |
| #14 | Inceptus Medical, LLC | 6 |
| #15 | Bard Peripheral Vascular, Inc. | 5 |
| #16 | Ratier-figeac SAS | 5 |
| #17 | Clph, LLC | 5 |
| #18 | 480 Biomedical Inc. | 5 |
| #19 | Syntorr Inc. | 5 |
| #20 | Fuse London Ltd | 5 |
Footprint here vs. claim strategy
Each dot is a leading D04C assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Classes near D04C's 584-grant footprint
Nationwide nearest neighbors for D04C (#521 of 670 by volume ; lead share 5.0%) - not the D04 parent-class siblings above.
Questions about D04C
Which company holds the most patents in D04C?
Which D04C assignees grew fastest recently?
How does D04C compare inside parent class D04?
What to do with this data
D04C in context - here's where to go next.
- Boston Scientific Scimed, Inc. leads D04C with 23 grants in this class. See full portfolio
- D04C ranks #521 of 670 by grant volume among all tracked CPC technology areas. See the ranking
- Inside parent class D04, the largest sibling subclass is D04H with 3,452 grants. Explore D04H
Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.
Methodology - D04C figures are USPTO PatentsView granted-utility totals for this subclass (584 grants in the tracked window).
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.